Empowering Advocacy Through Regulatory Insight: EMA Training for Bleeding Disorders Community
The European Haemophilia Consortium shared a thrilled post on advancing advocacy on X:
”Great to participate in European Medicines Agency training for patients and healthcare professionals! EHC SC Member Marius Tanase joined sessions on scientific advice, regulatory pathways and document review. Valuable insights for Patient Advocacy work!”
Great representation from the bleeding disorders community at the European Medicines Agency (EMA)!
EHC Steering Committee Member Marius Tanase recently took part in a specialized training organized by the EMA for patients and healthcare professionals.
This hands-on experience provided valuable insights that will directly strengthen the efforts, ensuring that patient voices remain central to therapeutic innovation and decision-making processes!
Learn more on coming conferences and trainings in Hemostasis Today.
-
Feb 25, 2026, 09:14Nominations are Open for 2027 Committee and Leadership Positions – ASH
-
Feb 25, 2026, 09:08Bastu Odoka: Closing the Gap on Anti-D Prophylaxis in Maternal Care
-
Feb 25, 2026, 08:53Eiman Alzaabi: Sharing Rare Observations and Challenging Assumptions in Transfusion Medicine
-
Feb 25, 2026, 08:40Matthew Flick։ A Great Gordon Research Conference on Plasminogen Activation and Extracellular Proteolysis
-
Feb 24, 2026, 16:18Salmaan Dalvi: Mapping Rare Diseases Across East and Central Africa
-
Feb 24, 2026, 16:16Wolfgang Miesbach: Game‑Changing Data on Intensive FVIII Replacement in Haemophilia A with Hypertrophic Synovium
-
Feb 24, 2026, 16:01Is It Safe to Briefly Stop Anticoagulation After VTE? – RPTH Journal
-
Feb 24, 2026, 15:58Anastasia Conti: Honored to Receive the Roche Foundation Grant for Independent Research in Onco-Hematology
-
Feb 24, 2026, 15:55Courtney Lawrence: Targeted Donor Screening Reduces Transfusion-Transmitted Babesia Cases